Skip to content

IAS: Rifampin TB treatment does not reduce response to NNRTIs, South Africans report

IAS: Exercise of benefit for lipodystrophy

IAS: DART trial shows AZT/3TC/tenofovir effective in majority after one year

IAS: WHO clinical staging excluding many without symptoms from HIV treatment, despite need

IAS: Studies in Uganda show generic fixed-dose combinations safe and effective in children with HIV

Tipranavir moves closer to approval in Europe

IAS: High risk of death for South Africans in first six months of ART, isoniazid may reduce risk

IAS: Columbia University is coordinating treatment scale at multiple sites in several sub-Saharan African countries

IAS: 3TC infant prophylaxis during breast-feeding reduces HIV infection rate at six months